LATS1 and cervical carcinoma: Intriguingly, AREG was able to suppress phosphorylation of LATS1, MOB1, and YAP in the cervical cancer cells, suggesting that AREG is not only a downstream target of the Hippo pathway, but also an important upstream regulator of the Hippo/YAP signaling pathway.